Physician profile
Amy Williams
NPI 1649668278
$1,822.75
in general payments reported to CMS, 2019-2025
24 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,293 · 2022: $498 · 2023: $32.08.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $32.08.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $32.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $677.96 | 2021-2022 | |
| Biohaven Pharmaceuticals, INC. | $208.06 | 2021 | |
| Sanofi-Aventis U.S. LLC | $127.04 | 2021 | |
| Esperion Therapeutics, INC. | $116.01 | 2021 | |
| Insulet Corporation | $95.35 | 2021-2023 | Omnipod |
| Novartis Pharmaceuticals Corporation | $74.99 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $73.94 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $53.69 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $46.87 | 2021 | |
| Amarin Pharma, INC. | $37.33 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $37.17 | 2021-2022 | |
| Ironwood Pharmaceuticals, INC | $31.58 | 2021 | |
| Neurelis, INC. | $27.73 | 2021 | |
| Lilly USA, LLC | $27.50 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $26.74 | 2021-2022 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $24.70 | 2021 | |
| Dexcom, INC. | $21.40 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $20.39 | 2022 | |
| Eisai INC. | $17.66 | 2022 | |
| Merck Sharp & Dohme LLC | $17.23 | 2021 | |
| Biogen, INC. | $16.49 | 2021 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $15.42 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $14.31 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $13.19 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Williams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.